MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0005848
Amn Life Science Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹273.11 Cr
▲ 42% YoY
Net profit · FY 2025
₹22.39 Cr
Net margin 8.2%
EBITDA · FY 2025
₹43.73 Cr
EBITDA margin 16%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹121.37 Cr
Satisfied ₹19.18 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
183
Provident fund records
About Amn Life Science Private Limited
Data last updated:
Amn Life Science Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 May 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC140663. Its GSTIN is 27AAECA4007A1ZF (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹4 Cr. It is led by directors Ashish Vijay Khemka (Managing Director) and Reshma Ashish Khemka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 811 – A The Capital Bandra – Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051.
As per the financials filed for FY 2025, the company reported a revenue of ₹273.11 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹22.39 Cr (net margin 8.2%) and EBITDA of ₹43.73 Cr (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 17% over five years.
The company has about 183 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: AMN Life Science. As per MCA filings, the company has open charges of ₹121.37 Cr and satisfied charges of ₹19.18 Cr on record. Court records list 17 cases involving the company, including 10 filed by the company and 7 filed against it; 8 cases are pending. The company has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 acquisition), with disclosed funding of ₹80 Lakh; the latest was in March 2014. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 4 smaller; the largest is Amanta Healthcare Limited with revenue of ₹276.09 Cr.
Amn Life Science Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0005848). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amnlife.com.
Company details
CIN U24230MH2003PTC140663
Registration Number 140663
Incorporation Date 30 May 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0005848
Recognitions & Rankings of Amn Life Science
Contact details
Amn Life Science Private Limited's registered office is in Mumbai, Maharashtra. Its website is amnlife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address811 – A The Capital Bandra – Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Amn Life Science Private Limited, buy the company report.
Comprehensive company report
Amn Life Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Amn Life Science operates one associated brand: AMN Life Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets pharmaceutical products internationally with over 300 formulations. | amnlife.com |
Business activity
The main business activity of Amn Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amn Life Science Private Limited, buy the company report.
Financials of Amn Life Science Private Limited
FY 2025 filings availableAmn Life Science Private Limited reported revenue of ₹273.11 Cr (up 42% YoY) for FY 2025.
Revenue · FY 2025
₹273.11 Cr ▲ 42%
Net profit · FY 2025
₹22.39 Cr margin 8.2%
EBITDA · FY 2025
₹43.73 Cr margin 16%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 17%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 105%
3 years · compounded
▲ 49%
5 years · compounded
▲ 30%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 42% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43.73 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amn Life Science Private Limited, buy the company report.
Board of directors of Amn Life Science Private Limited
Amn Life Science has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reshma Ashish Khemka | Director | 06 Feb 2006 | 20 Years 8 Months | Current |
| Ashish Vijay Khemka | Managing Director | 30 May 2003 | 23 Years 4 Months | Current |
Peer comparison
Amn Life Science Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amanta Healthcare Limited | ₹276.09 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Amn Life Science Private Limitedthis company | ₹273.11 Cr (FY 2025) | ₹22.39 Cr | 8.2% | 42.0% | 183 | Mumbai, Maharashtra, India |
| Selmar Lab Private Limited | ₹269.27 Cr (FY 2024) | -14.0% | Hyderabad, Telangana, India | |||
| Til Healthcare Private Limited | ₹266.59 Cr (FY 2025) | 13.0% | Chennai, Tamil Nadu, India | |||
| Panacea Biotec Pharma Limited | ₹265.23 Cr (FY 2025) | 26.0% | New Delhi, Delhi, India | |||
| Dey's Medical Stores Pvt Ltd | ₹262.47 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Amn Life Science Private Limited, buy the company report.
Auditor
Amn Life Science Private Limited is audited by S G C O & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S G C O & Co. LLP | FY 2024 | 112081W/W100184 |
Shareholding
The shareholding of Amn Life Science Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amn Life Science Private Limited, buy the company report.
Charges & borrowings
Open charges
₹121.37 Cr
Satisfied charges
₹19.18 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2025 | 101152425 | Others | ₹5 Cr | Open | |
| 17 Apr 2025 | 101096724 | Sidbi | ₹2.32 Cr | Open | |
| 28 Mar 2024 | 100914458 | Sidbi | ₹3 Cr | Open | |
| 21 Mar 2024 | 100908681 | Sidbi | ₹4.49 Cr | Open | |
| 27 Dec 2023 | 100850662 | Sidbi | ₹7.25 Cr | Open |
To see the full charge records of Amn Life Science Private Limited, buy the company report.
Total charge records: 23 View all charges
Deals & funding
Amn Life Science Private Limited has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 acquisition), with disclosed funding of ₹80 Lakh; the latest was in March 2014.
Total deals
5
Funding rounds
2
Secondary share transfers
2
Acquisition
1
Disclosed funding
₹80 Lakh
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Funding round | ₹55 Lakh | Investors: 2 individuals |
| Mar 2009 | Funding round | ₹25 Lakh | Investors: 2 individuals |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Acquisition | ₹10 Lakh | Buyer: an individual |
| Mar 2006 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amn Life Science Private Limited has 17 court cases on record: 10 filed by Amn Life Science, 7 filed against it. 8 cases are pending and 9 are disposed.
Total cases
17
Filed by the company
10
Filed against the company
7
Pending
8
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 4 | 4 |
| High courts | 7 | 2 | 4 |
| NCLT | 1 | 0 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (2406-Indirect Taxation : Goods and Services Tax, Integrated Goods and Services Tax, State Goods and Services Tax, UT Goods and Services Tax.) | Filed against the company by Union of India and 161 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against Iftex Oil and Chemicals Ltd. and 7 Ors | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Iftex Oil and Chemicals Ltd. and 7 Ors and 7 others | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Iftex Oil and Chemicals Ltd. and 7 Ors | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against Iftex Oil and Chemicals Ltd. and 7 Ors | Disposed |
To see the full case history of Amn Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amn Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Amn Life Science has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Amn Life Private Limited | U24100MH2020PTC343922 |
To see the full group structure of Amn Life Science Private Limited, buy the company report.
Employees & EPFO
Amn Life Science Private Limited has a workforce of 183 employees on its EPFO records as of Oct 11, 2025, across 1 active EPFO establishment.
Employee count
183
Active EPFO establishments
1
Employee growth
7.65%
GST
Amn Life Science has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECA4007A1ZF | Maharashtra | Active | 01 Jul 2017 |
| 24AAECA4007A1ZL | Gujarat | Active | 01 Jul 2017 |
| 02AAECA4007A1ZR | Himachal Pradesh | Active | 09 Apr 2022 |
To see the full GST registrations and return filing status of Amn Life Science Private Limited, buy the company report.
Recent activity
Amn Life Science Private Limited has 3 board changes on record since 2003: 2 appointments and 1 cessation. The latest: Ashish Vijay Khemka ceased to be Director on 19 Jul 2019.
AGM
Amn Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101152425 was registered on 12 Sep 2025.
Charges
A charge with Others of Rs. 15.00 Cr registered on 12 Dec 2023 with Charge ID 100842234 was modified on 29 Apr 2025.
Charges
A charge with Sidbi amounted to Rs. 2.32 Cr with Charge ID 101096724 was registered on 17 Apr 2025.
Filing
Amn Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Sidbi of Rs. 3.00 Cr registered on 28 Mar 2024 with Charge ID 100914458 was modified on 04 Apr 2024.
Charges
A charge with Sidbi amounted to Rs. 3.00 Cr with Charge ID 100914458 was registered on 28 Mar 2024.
Charges
A charge with Sidbi amounted to Rs. 4.49 Cr with Charge ID 100908681 was registered on 21 Mar 2024.
Charges
A charge with Sidbi amounted to Rs. 7.25 Cr with Charge ID 100850662 was registered on 27 Dec 2023.
Charges
A charge with Sidbi amounted to Rs. 7.25 Cr with Charge ID 100846894 was registered on 26 Dec 2023.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100842234 was registered on 12 Dec 2023.
Charges
A charge with Sidbi amounted to Rs. 10.00 Cr with Charge ID 100744004 was registered on 23 Jun 2023.
27 earlier events are in the company report.
Frequently asked questions
Amn Life Science is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 May 2003 (23+ years old) and is registered under CIN U24230MH2003PTC140663.
Amn Life Science has 2 current directors:
- Ashish Vijay Khemka - Managing Director
- Reshma Ashish Khemka - Director
The latest financial statements of Amn Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Amn Life Science is 27AAECA4007A1ZF, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 24AAECA4007A1ZL (Gujarat), 02AAECA4007A1ZR (Himachal Pradesh).
The CIN (Corporate Identification Number) of Amn Life Science is U24230MH2003PTC140663. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amn Life Science has 17 court cases on record: 10 filed by the company and 7 filed against it. 8 are pending. Most are in the district courts.
Amn Life Science was incorporated on 30 May 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Amn Life Science has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 acquisition), with disclosed funding of ₹80 Lakh; the latest was in March 2014.
The peers of Amn Life Science by revenue are Amanta Healthcare Limited, Selmar Lab Private Limited, Til Healthcare Private Limited, Panacea Biotec Pharma Limited, Dey's Medical Stores Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashish Vijay Khemka ceased to be Director on 19 Jul 2019. Reshma Ashish Khemka was appointed as Director on 06 Feb 2006. Ashish Vijay Khemka was appointed as Managing Director on 30 May 2003.
Yes, Amn Life Science is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0005848).